TCC transforms ICU healthcare delivery with €20M raise

Remote monitoring healthcare provider TCC has raised €20 million Series A funding from German ship owner and logistics entrepreneur Captain Thomas Pötzsch. 

Founded by Prof Dr Christian Storm and David Barg. TCC launched in 2022 in digital remote care for intensive care units (ICUs) 

The Tele-ICU team with one highly experienced intensivist, can provide service for 100 or more ICU patients at any time by leveraging high quality telemedicine clinical decision support, made possible by predictive algorithms and AI.

Machine learning enables the tele-ICU team to identify patterns in large data sets of high-frequency, real-time patient data (e.g. vital parameters, laboratory results, ventilator setup, etc.) to provide support that can range from detection of unintentional pharmaceutical interactions to prediction of deterioration and outcome of ICU patients.

Using TCC’s platform, over 10 trained intensive care physicians provide numerous hospitals with 24/7 support through telehealth services and risk analysis and prevention from the Hamburg and Berlin locations. 

TCC's customers include Unfallkrankenhaus Berlin, Krankenhaus Region Hannover (KRH) with six clinics, the University Medical Centre Schleswig-Holstein (UKSH) in Lübeck and Netcare South Africa, a hospital network of 44 hospitals with 9,000 beds (including 1,000 ICUs). 

“With this successful financing round, we are in a position to drive forward our successful algorithm development programme on the way to a holistic digital twin,” explains Prof Dr Christian Storm, CEO and co-founder of TCC.

According to Captain Thomas Pötzsch, TCC closes the demographic gaps in hospitals by optimising resources. 

“We were so impressed by the idea and the development status of TCC that we will be supporting TCC with our commitment over the next few years.” 

The fresh capital will primarily fund algorithm development to predict health deterioration. An algorithm for predicting sepsis with 80 per cent probability is about to be approved as a medical product. Further predictive algorithms focused on kidney failure will follow.

Lead image: David Barg and Professor Christian Storm, founders of TCC.